Cynosure, Inc.  

(Public, NASDAQ:CYNO)   Watch this stock  
Find more results for CYNO
44.85
+0.30 (0.67%)
After Hours: 44.71 -0.14 (-0.32%)
Dec 8, 5:19PM EST  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 44.00 - 45.00
52 week 32.90 - 55.94
Open 44.40
Vol / Avg. 199,969.00/398,476.00
Mkt cap 1.07B
P/E 50.94
Div/yield     -
EPS 0.88
Shares 23.60M
Beta 1.70
Inst. own 102%
Feb 7, 2017
Q4 2016 Cynosure Inc Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Nov 16, 2016
Cynosure Inc at Stifel Healthcare Conference
Oct 25, 2016
Q3 2016 Cynosure Inc Earnings Release
Oct 25, 2016
Q3 2016 Cynosure Inc Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin 3.91% 4.66%
Operating margin 7.67% 7.75%
EBITD margin - 14.50%
Return on average assets 2.93% 3.19%
Return on average equity 3.75% 4.15%
Employees 857 -
CDP Score - -

Address

5 Carlisle Rd
WESTFORD, MA 01886-3601
United States - Map
+1-978-2564200 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Cynosure Inc. (Cynosure) develops and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, reduce fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands and improve gynecologic health. The Company operates through aesthetic treatment products and services segment. It markets radiofrequency (RF) energy sourced medical devices for precision surgical applications, such as facial plastic and general surgery; gynecology; ear, nose and throat procedures; ophthalmology; oral and maxillofacial surgery; podiatry, and proctology. The Company's product portfolio utilizes a range of energy sources, including Alexandrite, diode, neodymium-doped yttrium aluminum garnet (Nd: YAG), pulse dye, Q-switched lasers, intense pulsed light and RF technology.

Officers and directors

Michael R. Davin Chairman of the Board, President, Chief Executive Officer
Age: 58
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Stephen J. Webber Chief Financial Officer, Executive Vice President, Chief Accounting Officer, Treasurer
Age: 46
Bio & Compensation  - Reuters
Douglas J. Delaney Chief Commercial Officer
Age: 47
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
William O. Flannery Lead Independent Director
Age: 68
Bio & Compensation  - Reuters
Brian M. Barefoot Independent Director
Age: 71
Bio & Compensation  - Reuters
Ettore V. Biagioni Independent Director
Age: 56
Bio & Compensation  - Reuters
Marina Hatsopoulos Independent Director
Age: 49
Bio & Compensation  - Reuters
Thomas H. Robinson Independent Director
Age: 56
Bio & Compensation  - Reuters